Editas licenses CRISPR patents to Vertex in $100 million-plus deal

Editas licenses CRISPR patents to Vertex in $100 million-plus deal

The speedy agreement prevents litigation between the two parties, but other Cas9 disputes may be on the cards

Unlock unlimited access to all IAM content